Correlation Between Xilio Development and Enliven Therapeutics

Can any of the company-specific risk be diversified away by investing in both Xilio Development and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xilio Development and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Xilio Development and Enliven Therapeutics, you can compare the effects of market volatilities on Xilio Development and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xilio Development with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xilio Development and Enliven Therapeutics.

Diversification Opportunities for Xilio Development and Enliven Therapeutics

0.35

Correlation Coefficient

Xilio Development  Enliven Therapeutics

Weak diversification

The 3 months correlation between Xilio and Enliven is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Xilio Development and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Xilio Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xilio Development are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Xilio Development i.e., Xilio Development and Enliven Therapeutics go up and down completely randomly.

Pair Corralation between Xilio Development and Enliven Therapeutics

Considering the 90-day investment horizon Xilio Development is expected to generate 5.16 times more return on investment than Enliven Therapeutics. However, Xilio Development is 5.16 times more volatile than Enliven Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  97.00  in Xilio Development on December 28, 2024 and sell it today you would lose (24.00) from holding Xilio Development or give up 24.74% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Xilio Development  vs.  Enliven Therapeutics

Xilio Development

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Xilio Development are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Xilio Development displayed solid returns over the last few months and may actually be approaching a breakup point.

Enliven Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Enliven Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Enliven Therapeutics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Xilio Development and Enliven Therapeutics

The main advantage of trading using opposite Xilio Development and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xilio Development position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.

The idea behind Xilio Development and Enliven Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.